Literature DB >> 2148286

Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease.

L Rozendaal1, S T Pals, E Gleichmann, C J Melief.   

Abstract

Induction of a graft-versus-host (GVH) reaction (GVHR) in non-irradiated (C57BL/10ScSn x DBA/2)F1 mice (BDF1) with DBA/2 lymphoid cells leads to chronic GVH disease (GVHD). One of the pathological alterations of this type of GVHD is hyperplasia of host B cells with production of lupus-like autoantibodies. This hyperstimulation of host B cells has previously been demonstrated to be induced by alloreactive donor T helper cells that were also proposed to maintain it. We provide three pieces of experimental evidence in support of this concept. First, treatment of mice with chronic GVHD by injection of monoclonal anti-Thy-1.2 antibodies, performed at week 6 after the injection of C57BL/6 lymphoid cells into (C57BL/6 x C57BL.bm12)F1 mice led to a significant decrease in the titre of anti-nuclear antibodies. Second, CD4+ donor T cells persisted in BDF1 mice with GVHD (GVHF1) for at least 10 weeks after the induction of GVHR; these T cells showed alloreactive helper activity against H-2b MHC determinants of the opposite parent in vitro. Third, T cells of GVHF1 mice, obtained 2 months after the induction of GVHR and transferred into normal secondary recipients, induced signs of chronic GVHD in DBF1 but not in DBA/2 mice. The combined results show that persisting donor T helper cells in GVHF1 mice retain their alloreactivity towards H-2 class II antigens for a long time after the induction of GVHR and they strongly suggest that these T cells are also the driving force behind the production of lupus-like autoantibodies at the late stage of chronic GVHD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148286      PMCID: PMC1535512          DOI: 10.1111/j.1365-2249.1990.tb05484.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.

Authors:  I F McKenzie; G M Morgan; M S Sandrin; M M Michaelides; R W Melvold; H I Kohn
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

2.  Renal allograft rejection induces MHC class II upregulation in autologous kidney and liver of the recipient.

Authors:  S M Miller; R Gupta; S H Lee; P Belitsky
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 3.  T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease.

Authors:  C S Via; G M Shearer
Journal:  Immunol Today       Date:  1988 Jul-Aug

Review 4.  Autoimmunity: polyclonal activation or antigen induction?

Authors:  R Dziarski
Journal:  Immunol Today       Date:  1988-11

5.  Acquisition and maturation of expressed B cell repertoires in normal and autoimmune mice.

Authors:  D M Klinman; Y Ishigatsubo; A D Steinberg
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

6.  Heterogeneity of mouse Thy 1.2 antigen expression revealed by monoclonal antibodies.

Authors:  P Del Guercio; I Motta; P Metezeau; S Brugere; R Perret; P Truffa-Bachi
Journal:  Cell Immunol       Date:  1982-10       Impact factor: 4.868

7.  The induction of organ-specific antibodies during the graft-vs.-host reaction.

Authors:  R C Kuppers; T Suiter; E Gleichmann; N R Rose
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

8.  Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis.

Authors:  A G Rolink; H Gleichmann; E Gleichmann
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

Review 9.  Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens?

Authors:  E Gleichmann; H Gleichmann; W Wilke
Journal:  Transplant Rev       Date:  1976

10.  A new model for investigations of T-cell functions in mice: differential immunosuppressive effects of two monoclonal anti-Thy-1.2 antibodies.

Authors:  H G Opitz; U Opitz; G Hewlett; H D Schlumberger
Journal:  Immunobiology       Date:  1982-02       Impact factor: 3.144

View more
  9 in total

1.  Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.

Authors:  Anthony D Foster; Mark Haas; Irina Puliaeva; Kateryna Soloviova; Roman Puliaev; Charles S Via
Journal:  Clin Immunol       Date:  2010-05-06       Impact factor: 3.969

2.  The influence of donor and recipient strains in isolated small bowel transplantation in rats.

Authors:  M Tanabe; N Murase; A J Demetris; R A Hoffman; K Nakamura; S Fujisaki; F H Galvao; S Todo; J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1994-12       Impact factor: 1.066

3.  Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.

Authors:  A Kretz-Rommel; S R Duncan; R L Rubin
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 4.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

5.  Characteristics of graft-versus-host disease after Lewis-to-brown-Norway rat small bowel transplantation.

Authors:  M Tanabe; N Murase; A J Demetris; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

6.  Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.

Authors:  F H Durie; A Aruffo; J Ledbetter; K M Crassi; W R Green; L D Fast; R J Noelle
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

Review 7.  Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.

Authors:  Jacopo Olivieri; Sabrina Coluzzi; Imma Attolico; Attilio Olivieri
Journal:  ScientificWorldJournal       Date:  2011-10-25

Review 8.  TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease.

Authors:  Young-Kwan Lee; Myungsoo Kang; Eun Young Choi
Journal:  Immune Netw       Date:  2017-06-20       Impact factor: 6.303

Review 9.  Dissecting complex epigenetic alterations in human lupus.

Authors:  Dipak R Patel; Bruce C Richardson
Journal:  Arthritis Res Ther       Date:  2013-01-29       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.